Since its founding in 2010, AIM, the Alzheimer’s Association and our advocates have been unrelenting in our fight for a world without Alzheimer’s and all other dementia. By securing robust increases for Alzheimer's and dementia research funding and advancing critical legislation, we have made a positive and meaningful impact on people living with Alzheimer's and their caregivers.

We’re making great progress against Alzheimer’s but much more work remains. Join us to keep up the momentum!

Changing the Trajectory Chart

Changing the Trajectory of Alzheimer’s Disease

The 2011 enactment of the landmark National Alzheimer’s Project Act (NAPA) ushered in a new era, changing the way our nation addresses Alzheimer’s and all other dementia.

2022 state funding

Securing Historic Dementia-Specific Funding in States

Thanks to the hard work of AIM advocates, state governments approved a record-breaking $164.2 million in dementia-specific funding in 2022. Factoring in varying budget cycles throughout the states, this number increases to $177.7 — representing an 8.6% increase in total funding across 35 states and the District of Columbia from the previous year. 

Doctor with Patient

Creating a Public Health Infrastructure

AIM was instrumental in the development, introduction and passage of the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act in 2018.

NIH Research Funding, 2023

Investing in Alzheimer’s Research

Through our committed advocacy network, AIM has helped secure a seven-fold increase in Alzheimer’s and dementia research funding since 2011.

Maryland’s Advocates Achieve Legislative Wins

Thanks to our hardworking advocates in states like Maryland, AIM is leading the way to pass laws that improve the lives of those living with dementia and their caregivers. In Maryland’s 2022 legislative session, advocates worked to develop, introduce and grow support for several bills that became laws.

Doctor with Patient

Ensuring Equity in Alzheimer’s Clinical Trials

The ENACT Act is working to increase the participation of underrepresented populations in Alzheimer’s and other dementia clinical trials by expanding education and outreach to these populations, encouraging the diversity of clinical trial staff, and reducing participation burden, among other priorities.

Masked doctor with patient

Victory for Alzheimer’s Care Planning

The Improving HOPE for Alzheimer’s Act is helping people living with dementia and their caregivers by educating clinicians on care planning services available through Medicare.

AA Woman Generic patient

Protecting Seniors from Abuse

People living with Alzheimer’s and other dementia are at heightened risk for experiencing elder abuse. Thanks to our dedicated advocates, individuals living with Alzheimer’s now have better protection from elder abuse because of the passage of the Promoting Alzheimer’s Awareness to Prevent Elder Abuse Act.

Group of Advocates in Purple

Donate to AIM

Help fight Alzheimer’s and all other dementia. Please join us as we continue our important work to advance Alzheimer’s policies across the nation. 

Federal Priorities

Access to Treatment

A restrictive Centers for Medicare & Medicaid Services (CMS) policy that only applies to those living with Alzheimer’s disease is blocking access to FDA-approved treatments. CMS must reverse its unprecedented decision that denies Medicare coverage of current and future treatments for Alzheimer’s.

A National Response to Alzheimer’s and Other Dementia

The bipartisan NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act would build on the progress made over the last decade by continuing to promote rapid research and improve the delivery of clinical care and services for people living with Alzheimer’s.

Large Group Advocates Waving State Flags

Nationwide State Priorities

AIM is working with state lawmakers to implement policies to improve the lives of people living with Alzheimer’s and other dementia, and their caregivers. Explore the issues.